Search

everythinglearnresearchcommunity

for

Search:↓

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Skin reactions from cancer treatments might predict how well the treatments work.

The scalp's microorganisms significantly affect hair health and disease.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

ILC1-like cells can independently cause alopecia areata.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Gut bacteria may influence hair loss in alopecia areata.

A cat's skin condition was fully cured with cyclosporine A after other treatments failed.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.